Quarterly report pursuant to Section 13 or 15(d)

DESCRIPTION OF THE COMPANY

v3.7.0.1
DESCRIPTION OF THE COMPANY
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
DESCRIPTION OF THE COMPANY

MedoveX Corp. (the “Company”) was incorporated in Nevada on July 30, 2013 as SpineZ Corp. (“SpineZ”) and changed its name to MedoveX Corp. on March 20, 2014. MedoveX is the parent company of Debride Inc. (“Debride”), which was incorporated under the laws of the State of Florida on October 1, 2012. The Company is in the business of designing and marketing proprietary medical devices for commercial use in the United States and Europe. The Company received CE marking in June 2017 for the DenerveX System and it is now commercially available throughout the European Union and countries that accept CE Mark. The Company is currently seeking approval for the DenerveX System from the FDA in the US.